Rate cuts appear to be off the table for now due to surging inflation and a relatively strong jobs market. The current dynamics could drive increased market volatility, but they could also make dependable income more appealing to investors.
When interest rates remain elevated and economic uncertainty persists, dividend-paying stocks serve a different purpose than they do in low-rate environments. During periods of declining rates, growth stocks typically outperform because lower rates increase the present value of future earnings. When rates stay high and growth slows, dividend stocks provide current income that compensates for limited capital appreciation.
The good news is that there are plenty of stocks that offer attractive dividends and are good picks. Three high-yield dividend stocks offer compelling yields backed by genuine business quality and long histories of dividend increases.
Why Dividend Stocks Matter in This Environment
Dividend investing creates a hybrid return profile combining current income with long-term capital appreciation potential. A 4% dividend yield means you’re earning annual return through cash payments regardless of whether the stock price rises or falls. This cushions against market volatility while providing tangible return.
During strong economic growth, investors can afford to wait years for capital appreciation from growth stocks. During uncertain environments with elevated interest rates, the certainty of dividend income becomes more valuable. You’re receiving cash that can be reinvested, spent, or used to average down on further declines.
The quality of the dividend matters enormously. High yields can signal financial distress if a company’s earnings can’t support the payout. Sustainable high-yield dividends come from profitable businesses with strong cash generation, manageable debt levels, and competitive positioning that allows them to maintain earnings and grow payments through economic cycles.
Three stocks currently offer yields ranging from 3% to nearly 6%, each backed by genuine business quality and proven commitment to returning capital to shareholders.
AbbVie Inc. (ABBV) trades around $223 and markets 12 blockbuster drugs, including autoimmune disease therapies Skyrizi and Rinvoq. The pharma stock is a member of the Dividend Kings, a group limited only to stocks with at least 50 consecutive dividend increases. AbbVie’s streak of dividend hikes now stands at 54 years, including the time it was part of Abbott Labs.
Dividend Kings represent the elite of dividend-paying companies. Reaching 50 consecutive years of dividend increases requires sustained profitability, strong cash generation, and management commitment to shareholder returns through multiple economic cycles. Fifty-four consecutive years demonstrates AbbVie’s reliability regardless of market conditions.
The dividend yield tops 3%, providing meaningful income while the company pursues growth. AbbVie is poised to deliver solid growth through multiple vectors. The company’s product lineup includes at least a dozen drugs whose sales increased by double digits year-over-year in the latest quarter.
More importantly for long-term investors, AbbVie’s pipeline includes around 60 programs in mid- or late-stage clinical studies that could fuel additional growth in the coming years. A robust pipeline provides visibility into future revenue growth extending years ahead. Successful drug launches can accelerate earnings growth beyond current consensus expectations.
Another plus for AbbVie is that its stock remains attractively valued despite delivering solid returns over the last 12 months. Shares trade at roughly 15.8 times forward earnings, well below the S&P 500 healthcare sector average of 17.2. This valuation discount suggests the market is underappreciating AbbVie’s dividend reliability and growth pipeline.
Pharmaceutical companies face regulatory risks, patent cliffs when blockbuster drugs lose exclusivity, and competition from generic alternatives. But AbbVie’s diversified portfolio of 12 blockbuster drugs reduces single-product risk. The pipeline provides replacement revenue as older drugs face generic competition.
Chevron Corporation (CVX) trades around $180 and is the world’s third-largest energy company by market cap—and the second-largest based in the U.S. Few companies are better positioned to benefit from the high energy prices driving inflation to soar than Chevron.
Chevron isn’t a member of the Dividend Kings yet. However, the company has increased its dividend for an impressive 39 consecutive years. Its dividend growth has handily outpaced top rivals ExxonMobil, Shell, BP, and Total Energies over the last two decades.
Chevron’s dividend yield of 3.73% is also one of the juiciest among major oil companies. This yield is supported by strong free cash flow from oil and gas operations. The company generates substantial cash when crude prices are elevated, allowing aggressive capital returns to shareholders.
The energy giant consistently rewards shareholders with what some call “invisible” dividends too—stock buybacks. Chevron has repurchased shares in 18 of the last 22 years. Management targets buybacks of between 3% and 6% of outstanding shares per year going forward. Share buybacks reduce share count, concentrating earnings per share among remaining shareholders.
Chevron expects to deliver average annual earnings-per-share growth of over 10%. Even if oil prices fall below $50 per barrel, Chevron will be able to fund the dividend and planned capital expenditures. This demonstrates the company’s operational efficiency—the dividend is sustainable even under stress scenarios.
The Iran war has driven higher demand for U.S.-produced energy as global supply concerns persist. Data centers hosting artificial intelligence applications require massive amounts of power, with natural gas providing an ideal fuel source. Chevron’s diversified energy portfolio spanning crude oil, natural gas, and downstream refining positions the company well to benefit from these long-term trends.
Energy stocks carry commodity price risk. If crude falls sharply or demand declines, cash flow and dividends could face pressure. But Chevron’s scale, operational efficiency, and diversification provide downside protection that smaller energy companies lack.
Enterprise Products Partners L.P. (EPD) trades around $37 and isn’t as well-known as Chevron, but represents one of the best energy stocks for income investors. The limited partnership is a leader in the U.S. midstream energy industry, operating over 50,000 miles of pipeline.
If you’re looking for an especially high yield, Enterprise could be just the ticket. Its distribution yield currently stands at 5.88%, nearly double AbbVie’s 3% yield and 57% higher than Chevron’s 3.73%. This high yield is backed by stable, contracted cash flows.
Enterprise Products Partners operates pipelines that transport energy products across the country. The business model is capital intensive but generates highly predictable cash flows. Most of Enterprise’s revenue comes from long-term contracts with energy producers and refineries. These contracts specify volume commitments or fixed fees, creating revenue visibility independent of commodity prices.
The company has increased its distribution for 27 consecutive years. This track record is shorter than AbbVie’s 54-year streak or Chevron’s 39-year streak, but demonstrates genuine commitment to returning capital to shareholders through the complete energy market cycle.
Enterprise Products Partners shouldn’t have any problems extending that streak. Its strong balance sheet has earned the company the highest credit rating in the midstream energy industry. Enterprise’s leverage ratio is a respectable 3.2x. Around 90% of its long-term contracts are insulated from inflation through escalation provisions.
These escalation clauses mean that when energy producers’ costs increase due to inflation, they pass those costs through to consumers, and Enterprise’s fees increase proportionally. This inflation hedging protects distributions even during inflationary periods.
The pipeline stock could deliver solid growth, too. The Iran war has driven higher demand for U.S.-produced natural gas liquids (NGLs). Data centers hosting AI applications require massive amounts of power, with natural gas providing an ideal fuel source. Enterprise’s energy infrastructure assets position the company well to benefit from these trends.
Limited partnerships like Enterprise have different tax treatment than regular corporations. Investors receive K-1 tax forms rather than 1099s, and must report partnership income on their individual returns. This complexity deters some investors, which can create valuation discounts. For investors comfortable with tax complexity, the higher yield can compensate.
